Further, the analysis also revealed the protective efficacy ( a ¼Po0.05, b ¼Po0.01) of 0.05% BC (T7) against T6 at 48 and 96 h in respect of anomalous nuclei (AN) (Histogram 1c in Appendix A).
Further, the analysis also revealed the protective efficacy ( a¼Po0.05, b ¼Po0.01) of 0.05% BC (T7) against T6 at 48 and 96 h in respect of anomalous nuclei (AN) (Histogram 1c in Appendix A).